Downregulation of striatal dopamine D2 receptors in advanced Parkinson's disease contributes to the development of motor fluctuation

被引:22
|
作者
Hwang, WJ
Yao, WJ
Wey, SP
Shen, LH
Ting, G
机构
[1] Natl Cheng Kung Univ, Dept Nucl Med, Coll Med, Tainan 704, Taiwan
[2] Natl Cheng Kung Univ, Dept Neurol, Coll Med, Tainan 704, Taiwan
[3] Inst Nucl Energy Res, Lungtan 32500, Taiwan
关键词
Parkinson's disease; dopamine D2 receptor; (123)l-IBZM SPECT;
D O I
10.1159/000047962
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The purpose of this study was to evaluate the contribution of the postsynaptic mechanism to the development of motor fluctuation in advanced Parkinson's disease (PD). We used I-123-iodobenzamide single-photon emission computed tomography to measure the striatal dopamine D2 receptor densities in early levodopa-naive PD, chronic PD with stable levodopa response, and advanced PD with fluctuating levodopa response. The basal ganglia/frontal cortex ratios at both hemispheres were calculated and averaged. PD patients with fluctuating levodopa response showed a significant decrease in striatal dopamine D2 receptor densities compared to those with early (1.57 +/- 0.20 vs. 1.77 +/- 0.12, p = 0.009) or chronic stable PD (1.57 +/- 0.20 vs. 1.77 +/- 0.10, p = 0.024). We conclude that the decreased D2 receptor densities in advanced PD reduced the 'safety factor' for synaptic transmission and contributed to the development of motor fluctuation. Copyright (C) 2002 S. Karger AG, Basel.
引用
收藏
页码:113 / 117
页数:5
相关论文
共 50 条
  • [21] Patterns of striatal dopamine depletion and motor deficits in de novo Parkinson’s disease
    Seong Ho Jeong
    Chan Wook Park
    Hye Sun Lee
    Yun Joong Kim
    Mijin Yun
    Phil Hyu Lee
    Young H. Sohn
    Seok Jong Chung
    Journal of Neural Transmission, 2023, 130 : 19 - 28
  • [22] Dopamine agonists in the treatment of motor complications in advanced Parkinson's disease
    Slawek, Jaroslaw
    NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2007, 41 (02) : S29 - S33
  • [23] Contribution of functional dopamine D2 and D3 receptor variants to motor and non-motor symptoms of early onset Parkinson's disease
    Eryilmaz, Isil Ezgi
    Erer, Sevda
    Zarifoglu, Mehmet
    Egeli, Unal
    Karakus, Ece
    Yurdacan, Beste
    Cecener, Gulsah
    Tunca, Berrin
    Colakoglu, Beril
    Tokcaer, Ayse Bora
    Saka, Esen
    Demirkiran, Meltem
    Akbostanci, Cenk
    Dogu, Okan
    Kaleagasi, Hakan
    Kenangil, Gulay
    Cakmur, Raif
    Elibol, Bulent
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2020, 199
  • [24] Choline acetyltransferase activity and striatal dopamine receptors in Parkinson's disease in relation to cognitive impairment
    Mattila, PM
    Röyttä, M
    Lönnberg, P
    Marjamäki, P
    Helenius, H
    Rinne, JO
    ACTA NEUROPATHOLOGICA, 2001, 102 (02) : 160 - 166
  • [25] Choline acetyltransferase activity and striatal dopamine receptors in Parkinson's disease in relation to cognitive impairment
    Abdou W.A.
    Aveline C.
    Bonnet F.
    Acta Neuropathologica, 2001, 102 (2) : 160 - 166
  • [26] Non-motor symptoms and striatal dopamine transporter binding in early Parkinson's disease
    Liu, Rui
    Umbach, David M.
    Troster, Alexander, I
    Huang, Xuemei
    Chen, Honglei
    PARKINSONISM & RELATED DISORDERS, 2020, 72 : 23 - 30
  • [27] [11C]-(+)-PHNO PET Imaging of Dopamine D2/3 Receptors in Parkinson's Disease With Impulse Control Disorders
    Payer, Doris E.
    Guttman, Mark
    Kish, Stephen J.
    Tong, Junchao
    Strafella, Antonio
    Zack, Martin
    Adams, John R.
    Rusjan, Pablo
    Houle, Sylvain
    Furukawa, Yoshiaki
    Wilson, Alan A.
    Boileau, Isabelle
    MOVEMENT DISORDERS, 2015, 30 (02) : 160 - 166
  • [28] Segregation of D1 and D2 dopamine receptors in the striatal direct and indirect pathways: An historical perspective
    Gerfen, Charles R. R.
    FRONTIERS IN SYNAPTIC NEUROSCIENCE, 2023, 14
  • [29] Efficacy of rasagiline in patients with advanced Parkinson's disease with motor fluctuation (AZIMUT study)
    Levin, O. S.
    Boiko, A. N.
    Ivanov, A. K.
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2010, 110 (11) : 42 - 47
  • [30] Dopamine D3 receptor is decreased and D2 receptor is elevated in the striatum of Parkinson's disease
    Ryoo, HL
    Pierrotti, D
    Joyce, JN
    MOVEMENT DISORDERS, 1998, 13 (05) : 788 - 797